MUHC researcher receives inaugural Canadian Cancer Society award

    NEXT STORY
    OSE Immunotherapeutics Announces €10.7 Million in Additional Public Funding, via Bpifrance, to Finance Further Development of CoVepiT, its Multi-Target and Multi-Variant COVID-19 Vaccine in Phase 1 Clinical Phase
    PREV STORY
    Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Insights on the Polymerase Chain Reaction for Point-of-Care Diagnostics Global Market to 2025 – Impact Analysis of COVID-19

    author_avatar
    NASDAQ Market News

    Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

    MINNEAPOLIS, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or ...

    author_avatar
    NASDAQ Market News

    Summit Medical Group to Implement Altura’s Novel HCP Studies™ Mobile Platform to Support Expanding Patient Access to Clinical Studies

    MISSION VIEJO, Calif. and BERKELEY HEIGHTS, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Altura, ...

    author_avatar
    NASDAQ Market News